A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...

Chronic obstructive pulmonary disease (COPD) is known for causing breathing difficulties and limiting everyday activities.

Incannex Healthcare Inc. (NASDAQ:IXHL) on Thursday detailed an updated clinical development plan for IHL-42X, its oral ...

A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...

Obstructive sleep apnea (OSA) is a common sleep disorder characterized by oxygen desaturation due to repeated airway collapse ...

Untreated obstructive sleep apnea is linked to billions in lost productivity in the US and UK, with absenteeism and reduced ...

Custom-fitted oral appliances reduce airway obstruction by physically repositioning the lower jaw or tongue forward during ...

A clinical trial shows sulthiame lowers breathing interruptions in sleep apnea and improves oxygen levels, raising hope for a medication alternative to CPAP therapy.

Healthy foods like nuts, berries, and fatty fish may be able to help ease obstructive sleep apnea symptoms. However, alcohol, ...

Incannex shares drop after announcing a $10 million stock offering to fund its IHL-42X sleep apnea study following positive ...